xestospongin-a has been researched along with herbimycin* in 1 studies
1 other study(ies) available for xestospongin-a and herbimycin
Article | Year |
---|---|
Participation of tyrosine kinase and phospholipase Cgamma in isradipine-induced proliferation of cultured human gingival fibroblasts.
Some kinds of drugs such as calcium (Ca(2+)) channel antagonists, antiepileptics and immunosuppressants cause gingival overgrowth as a side effect, the mechanism of which is still unclear. We have examined the effects of isradipine, one of the dihydropyridine-derivative Ca(2+) channel antagonists, on cultured human gingival fibroblast Gin-1 cells. In the present study, to elucidate the mechanism by which isradipine causes gingival overgrowth, we examined whether tyrosine kinase (TK) and phopholipase Cgamma (PLCgamma) are involved in the isradipine-induced proliferation of gingival fibroblasts. Herbimycin A (1 microM) remarkably inhibited the isradipime (10 microM)-induced proliferation. Both U73122 (5 microM), a PLCgamma inhibitor, and xestospongin C (5 microM), an antagonist of a receptor of inositol 1,4,5-trisphosphate in Ca(2+) stores, significantly reduced the [Ca(2+)]i raised by isradipine (10 microM). Thus, the findings obtained here indicate that TK and PLCgamma are closely involved in the isradipine-induced [Ca(2+)]i rise to elicit gingival overgrowth. Topics: Benzoquinones; Calcium Channel Blockers; Cell Proliferation; Cells, Cultured; Drug Interactions; Enzyme Inhibitors; Estrenes; Fibroblasts; Gingiva; Humans; Isradipine; Lactams, Macrocyclic; Macrocyclic Compounds; Oxazoles; Phospholipase C gamma; Protein-Tyrosine Kinases; Pyrrolidinones; Quinones; Rifabutin | 2005 |